Patents by Inventor Harald Tschesche

Harald Tschesche has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Utilisation of angiogenin and/or .alpha..sub.1 -microglobulin and/or complement factor D in order to inhibit the secretion of proteins
    Patent number: 6103691
    Abstract: The invention proposes a way to generally prevent or at least severely limit the secretion of proteins, particularly the secretion of enzymes from leucocytes. By administering an agent containing one or more active ingredients selected from the group consisting of angiogenine, .alpha..sub.1 -microglobulin, complement factor D, fragments or peptides with the biologically effective sequential ranges of these peptides, and peptidomimetica to the source of secretion the secretion can be prevented or at least drastically limited.
    Type: Grant
    Filed: March 5, 1996
    Date of Patent: August 15, 2000
    Inventors: Harald Tschesche, Ute Hempelmann
  • Homologues of aprotinin with, in place of lysine, other aminoacids in position 15, process for their preparation and their use as medicaments
    Patent number: 4595674
    Abstract: The invention relates to homologs of aprotinin with, in place of lysine, other amino acid moieties in position 15, methods for their preparation and their use as proteinase inhibitors.
    Type: Grant
    Filed: March 13, 1985
    Date of Patent: June 17, 1986
    Assignee: Bayer Aktiengesellschaft
    Inventors: Harald Tschesche, Herbert Wenzel, Rainer Schmuck, Eugen Schnabel
  • Deamino derivatives of the kallikrein-trypsin inhibitor
    Patent number: 4118481
    Abstract: A demaino kallikrein-trypsin inhibitor obtained from cattle organs is characterized by (a) 0 to 3 lysine residues and/or 3 to 6 arginine residues and/or 1 to 4 tyrosine residues; (b) the 10- and/or 21-tyrosine residues being unsubstituted or substituted by at least one nitro, nitroso or amino in the ortho position relative to the phenolic hydroxy group; and (c) having protease inhibitory activity of BPTI and elastase inhibition activity.
    Type: Grant
    Filed: April 29, 1977
    Date of Patent: October 3, 1978
    Assignee: Bayer Aktiengesellschaft
    Inventors: Eugen Schnabel, Horst Dieter Schlumberger, Gerd Reinhardt, Ernst Truscheit, Harald Tschesche